News

08 January 2018

Chas Bountra appointed OBE in UK's 2018 Honours List

Congratulations to Professor Chas Bountra, Chief Scientist at the SGC Oxford and Professor of Translational Medicine at the Nuffield Department of Medicine and who has been appointed OBE for…

27 November 2017

First batches of ULTRA-DD patient-based assay data released - ahead of publication

The ULTRA-DD project has made good on its promise to make its data open source with the publication online of…

28 September 2017

Takeda and SGC Announce a Collaboration Agreement Using Patient Tissue-Based Assays for Clinical Target Validation in Irritable Bowel Disease

Osaka, Japan, San Diego, Calif., USA, and Stockholm, Sweden, September 28, 2017— Takeda Pharmaceutical Company Limited (“Takeda”) (TSE: 4502), Karolinska Institutet (“KI”) and The…

04 August 2017

DiscoverX and the SGC Announce Major Milestone in Development of Kinase Chemogenomic Set

FREMONT, Calif., Aug. 3, 2017 /PRNewswire/ -- DiscoverX Corporation, the leading supplier of innovative cell-based assays and services for drug discovery and development, in collaboration with the…

20 July 2017

Kilian Huber receives research award from ThermoFisher

On June 5th, 2017, SGC Oxford's Kilian Huber was awarded a Bronze level…

23 May 2017

Open Innovation case studies

Putting open innovation into practice – case studies from Europe

An IMI symposium at the 6th Pharmaceutical Science World Congress (PSWC)

IMI is working to improve…

21 March 2017

Quality in research: Partnership for better antibodies

The international research consortium SGC and SciLifeLab aim to give researchers access to well-validated research tool antibodies.

12 January 2017

SGC Scientists Report the First Chemical Probe for PCAF Bromodomain

Oxford, UK, January 12, 2017, Scientists from the Structural Genomics Consortium (SGC) and Oxford University report the first potent and selective chemical probe for the bromodomain of PCAF in an…

19 December 2016

3D map of PC2 to jump-start drug discovery efforts in polycystic kidney disease

Oxford, UK, December 19, 2016, Scientists from the Structural Genomics Consortium (SGC) and Oxford University report a three-dimensional view of the Polycystin-2 (PC2), a protein that causes…

01 November 2016

IMI project partner wins public-private collaboration award

The Structural Genomics Consortium (SGC), one of the project partners in IMI’s ULTRA-DD project, won the …